| Financial Year |
March 31 2023 |
| Monetary Funds |
1,282,591,386.13 |
| Held-for-trading Financial Assets |
6,104,722.16 |
| Notes Receivable |
-- |
| Accounts Receivable |
467,967,342.42 |
| Advances to Suppliers |
138,222,341.00 |
| Other Receivables |
20,538,085.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
9,229,558.49 |
| Dividend Receivable |
-- |
| Inventories |
266,820,926.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,024,243.34 |
| Total Current Assets |
2,332,044,342.85 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
95,750,000.00 |
| Investment Properties |
1,062,408,098.83 |
| Fixed Assetes |
750,182,016.03 |
| Under-construction Projects |
23,977,062.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
155,472,313.12 |
| R&D expenses |
-- |
| Goodwill |
1,260,954.11 |
| Long-Term Deferred and Prepaid Expenses |
31,714,044.99 |
| Deferred Income Tax Assets |
8,328,186.64 |
| Other Non-Current Assets |
41,045,628.50 |
| Sub-Total of Non-Current Assets |
2,203,673,066.96 |
| Total Assets |
4,535,717,409.81 |
| Short-Term Loans |
330,392,081.97 |
| Trading Financial liabilities |
-- |
| Notes Payable |
52,376,664.36 |
| Accounts Payable |
173,932,753.00 |
| Accounts Received In Advance |
51,434,014.60 |
| Employee Compensation Payable |
15,817,705.85 |
| Taxes Payable |
51,939,274.40 |
| Interest Payable |
-- |
| Dividend Payable |
134,283.12 |
| Other payables |
129,995,309.60 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
19,171,546.10 |
| Other Current Liabilities |
1,957,593.45 |
| Sub-Total of Current Liabilities |
889,197,942.89 |
| Long-term Loans |
128,180,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,665,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,116,541.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
139,961,541.28 |
| Total Liabilities |
1,029,159,484.17 |
| Paid-In Capital(Or Share Stock) |
1,445,241,071.00 |
| Capital Surplus |
260,184,807.10 |
| Surplus Reserve |
358,903,755.33 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
876,196,418.13 |
| Minority Stockholder's Interest |
565,887,595.55 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,940,670,330.09 |
| Owner's Equity（Stockholder's Equity） |
3,506,557,925.64 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,535,717,409.81 |
